Clinical trial

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

NCT03017573

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2017-01-06

PhaseNA

Study timeline

Study start (actual)2017-01-06Date precision: day

Registry last updated2026-02-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ovarian Cancerunresolved

Triple-Negative Breast Cancerunresolved

Head and Neck Cancerunresolved

Cervical Cancerunresolved

Sarcomaunresolved

Vulva Cancerunresolved

Interventions

Tumor biopsies / Tumor surgeryPROCEDURE

Blood withdrawalPROCEDURE

Sponsors & collaborators

Institut Curielead sponsor

Mapped research locations

ParisFrance1 LyonFrance1 LilleFrance1 BordeauxFrance1 Vandœuvre-lès-NancyFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03017573 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.